“A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA CoA Ratio via Dual Inhibition of PPAT and CPT1A”. 2025. Journal of Cancer Research Updates 14 (December): 247-65. https://doi.org/10.30683/1929-2279.2025.14.26.